-
Je něco špatně v tomto záznamu ?
Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?
L. Riedlbauchová, V. Durdil, J. Honěk, J. Veselka,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
NV15-31398A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Free Medical Journals
od 2007 do Před 1 rokem
PubMed Central
od 2007 do Před 1 rokem
PubMed
32476811
DOI
10.1055/s-0040-1708529
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Atrial fibrillation is the most common arrhythmia in the adult population, and its incidence and prevalence are still rising. Cardiac devices are widely used in clinical practice in the management of various rhythm disturbances and heart failure treatment. Many patients who receive a pacemaker, implantable cardioverter-defibrillator, or cardiac resynchronization therapy also experience atrial fibrillation in the course of their life. Therefore, this review aims to describe the role of these devices in the treatment and prevention of atrial fibrillation in the device recipients. In addition, all these implantable devices also serve as permanent ECG (electrocardiogram) monitors, thus providing important information about the presence and characteristics of atrial fibrillation that may or may not be detected by the patient but can modify our therapeutical approach with regard to the stroke prevention.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20019113
- 003
- CZ-PrNML
- 005
- 20201123124115.0
- 007
- ta
- 008
- 201103s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1055/s-0040-1708529 $2 doi
- 035 __
- $a (PubMed)32476811
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Riedlbauchová, Lucie $u Department of Cardiology, Motol University Hospital, Prague, Czech Republic. Second Faculty of Medicine, Charles University, Prague, Czech Republic.
- 245 10
- $a Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy? / $c L. Riedlbauchová, V. Durdil, J. Honěk, J. Veselka,
- 520 9_
- $a Atrial fibrillation is the most common arrhythmia in the adult population, and its incidence and prevalence are still rising. Cardiac devices are widely used in clinical practice in the management of various rhythm disturbances and heart failure treatment. Many patients who receive a pacemaker, implantable cardioverter-defibrillator, or cardiac resynchronization therapy also experience atrial fibrillation in the course of their life. Therefore, this review aims to describe the role of these devices in the treatment and prevention of atrial fibrillation in the device recipients. In addition, all these implantable devices also serve as permanent ECG (electrocardiogram) monitors, thus providing important information about the presence and characteristics of atrial fibrillation that may or may not be detected by the patient but can modify our therapeutical approach with regard to the stroke prevention.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Durdil, Václav $u Department of Cardiology, Motol University Hospital, Prague, Czech Republic. Second Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Honěk, Jakub $u Department of Cardiology, Motol University Hospital, Prague, Czech Republic. Second Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Veselka, Josef $u Department of Cardiology, Motol University Hospital, Prague, Czech Republic. Second Faculty of Medicine, Charles University, Prague, Czech Republic.
- 773 0_
- $w MED00005745 $t The International journal of angiology : official publication of the International College of Angiology, Inc $x 1061-1711 $g Roč. 29, č. 2 (2020), s. 113-122
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32476811 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201103 $b ABA008
- 991 __
- $a 20201123124114 $b ABA008
- 999 __
- $a ind $b bmc $g 1585893 $s 1109311
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 29 $c 2 $d 113-122 $e 20200428 $i 1061-1711 $m International journal of angiology $n Int J Angiol $x MED00005745
- GRA __
- $a NV15-31398A $p MZ0
- LZP __
- $a Pubmed-20201103
